Send feedback

MYOC p.Pro481Ser

c.1441C>T · rs763068244 · VCV1686786

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 1 submitter
AlphaMissense
ambiguous
0.3412 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00891%, eas)
Missense predictors
1/2 damaging
REVEL, SaProt · AlphaMissense indeterminate
Conditions
1
open-angle glaucoma

ClinGen expert panel — Glaucoma VCEP

Uncertain Significance for open-angle glaucoma. Applied ACMG criteria (verbatim):

PM2_Supporting PP3

Curation rationale (ClinGen, verbatim)

The c.1441C>T variant in MYOC is a missense variant predicted to cause substitution of Proline by Serine at amino acid 481 (p.Pro481Ser). The highest minor allele frequency of this variant was in the East Asian genetic ancestry group of gnomAD (v4.1.0) = 0.00008911 (4 alleles out of 44,888), which met the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.684, which was within the 0.644-0.772 range for PP3, predicting a damaging effect on MYOC function. The Pro481Ser protein was assessed in an assay (PMID: 35196929), however, the results for this protein were inconsistent and not included as evidence. Only 1 proband with primary open angle glaucoma had been reported (PMID: 15534471), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting. In summary, this variant met the criteria to receive a score of 2 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5, adapted from PMID: 32720330) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PP3, PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.3412ambiguous
REVEL0.684pathogenic-leaning
SaProtLLR -7.04tolerated
⇒ REVEL calls this damaging; SaProt does not; AlphaMissense is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 17 kb · p 0.038 · regional, not allelic
Overall
CADD26.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00891% East Asian · 4/44,888 alleles
Filtering AF 0.00298% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0018%
Overall 0.000248% 4/1,614,166 alleles · very rare exomes 4/1,461,888 · genomes 0/152,278 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYOC
Protein
p.Pro481Ser
Coding
c.1441C>T
MANE Select
NM_000261
dbSNP
rs763068244
Type
single nucleotide variant
Location
chr1:171635999 (GRCh38)
Gene constraint
LOEUF 1.343 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.40 · 24 PDB
Residue 481
a UniProt-annotated variant site (in glc1a); a UniProt-annotated variant site (in glc1a; uncertain significance); a turn; the olfactomedin-like domain
Full MYOC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myoc-p-pro481ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown